Artemis Hospitals
| India | Turkey | Austria | |
| Radiation therapy for colorectal cancer | from $3,200 | from $7,000 | from $12,000 |
| Chemotherapy for breast cancer | from $3,500 | from $1,200 | from $15,000 |
| Chemotherapy | from $550 | from $2,430 | from $2,500 |
| Bone marrow transplantation | from $15,000 | from $36,000 | from $140,000 |
| Autologous bone marrow transplantation | from $11,000 | from $31,000 | from $50,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Burkitt"s lymphoma treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Burkitt"s lymphoma treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Burkitt"s lymphoma treatment journey.
Pediatric hematologist-oncologist and bone marrow transplant specialist at Global Hospital Mumbai.
16 years of experience of expertise in leukemia, multiple myeloma, and bone marrow transplant – Dr. Badarkhe brings deep hematology-oncology experience to Burkitt's lymphoma cases.
Dr. Prakash Pandit specializes in Burkitt's lymphoma treatment using advanced techniques like Tomotherapy-H, Linear Accelerator, and Brachytherapy at HCG Manavata Cancer Centre.
Standard treatment in India involves intensive short-duration multi-agent chemo-immunotherapy combined with mandatory central nervous system prophylaxis. Indian hospitals primarily utilize R-CODOX-M/R-IVAC or DA-EPOCH-R regimens. These protocols incorporate Rituximab and intrathecal chemotherapy to manage this aggressive malignancy while preventing disease spread.
Bookimed Expert Insight: Data from top-tier Indian networks like Manipal and Apollo indicates a shift toward DA-EPOCH-R to minimize treatment abandonment. While R-CODOX-M is powerful, its requirement for advanced inpatient monitoring and prolonged stays can be challenging. Facilities like HCG Manavata and Dr. Rela Institute utilize precision technologies like linear accelerators with 1 mm accuracy for targeted cases, ensuring high-density treatment even in resource-limited settings.
Patient Consensus: Patients emphasize that treatment must start immediately after diagnosis as surgery alone is ineffective. They often note that the first chemotherapy cycle is the most critical period, requiring strict medical monitoring for rapid tumor breakdown.
Indian medical centers report a 3-year survival rate between 66% and 70% for Burkitt lymphoma. Specialized adult cohorts completing intensive therapy achieve a 73% 2-year survival rate. Pediatric success remains high at 70% when patients receive immediate treatment at hematology-oncology facilities.
Bookimed Expert Insight: Success in India often depends on high-volume centers with dedicated hematology units. Manipal Hospitals and Apollo Hospital Indraprastha each serve over 1,000,000 patients annually. Large networks like these maintain specialized oncology beds and critical care support. This infrastructure is essential for managing the intensive treatment required for Burkitt lymphoma.
Patient Consensus: Patients emphasize that speed is vital because this cancer progresses rapidly. Many note that while chemotherapy is physically demanding, tumor shrinkage often begins shortly after the first cycle.
Doctors emphasize central nervous system prophylaxis to prevent cancer cells from hiding in sanctuary sites. The blood-brain barrier blocks standard intravenous chemotherapy from reaching these areas. Preventative treatment targets microscopic disease in the brain and spinal fluid to avoid high-risk relapse.
Bookimed Expert Insight: Indian oncology centers often combine specialized radiation technologies with intensive chemotherapy protocols. Dr. Prakash Pandit at HCG Manavata Cancer Centre utilizes Tomotherapy-H for targeted tumor irradiation. This specialized equipment allows for precise dosing near critical nervous system structures. Choosing a clinic with both hematology-oncology and advanced radiation departments ensures seamless delivery of complex prophylaxis protocols.
Patient Consensus: Patients note that nervous system treatment is often more intense than expected. Many wish they had known about the regular lumbar punctures required to keep the spinal fluid clear.
Early diagnosis and immediate start of intensive chemotherapy are the most critical factors for long-term Burkitt lymphoma survival. This aggressive cancer doubles in size every 24 hours. Vital survival pillars include sentinel lymph node biopsy, PET-CT staging, and immediate access to hematology-oncology specialist care.
Bookimed Expert Insight: India’s top oncology centers like Apollo and Manipal manage over 1,000,000 patients annually. This massive volume ensures hematologists are prepared for rare, aggressive cancers. We notice that JCI-accredited clinics in Bengaluru and Delhi often offer IBM Watson for precision mapping. This helps doctors select the most effective regimens for rapid-growth tumors faster.
Patient Consensus: Patients emphasize that getting a fast biopsy and starting treatment immediately is life-saving. They note it is vital to find a team ready to handle intense side effects right away.
Surgery is not the primary treatment for Burkitt lymphoma because these tumors respond exceptionally well to chemotherapy. High-volume Indian centers prioritize systemic therapy over surgical resection. Doctors utilize surgery mainly for diagnostic biopsies or emergency complications like bowel obstructions, perforations, or intussusception requiring urgent repair.
Bookimed Expert Insight: Indian oncology centers like Artemis and Manipal focus on high-speed diagnostics rather than surgical removal to improve outcomes. Data shows top-tier facilities emphasize starting intensive chemotherapy immediately after biopsy. Centers like Global Hospital Chennai and Apollo Indraprastha handle over 1,000,000 patients annually. This massive volume ensures pathology teams can confirm Burkitt lymphoma quickly. This allows patients to bypass major surgical trauma and move straight to life-saving systemic treatments.
Patient Consensus: Patients note that surgery is almost always just a step for diagnosis or emergencies rather than the cure. They emphasize finding a center that can start chemotherapy quickly once the biopsy results are ready.
Burkitt lymphoma is highly curable in India when treated with intensive, multi-agent chemotherapy. Major oncology hubs achieve high remission rates by starting treatment immediately. Success depends on using dose-adjusted protocols like DA-EPOCH-R or CODOX-M/IVAC. These are combined with targeted therapies like rituximab to manage this aggressive cancer.
Bookimed Expert Insight: India is a unique choice for Burkitt lymphoma due to its massive patient volumes. Apollo Hospital Indraprastha has treated over 45 million patients from 120 countries. This immense scale means Indian haematologists manage rare, aggressive blood cancers more frequently than many Western specialists. This often leads to more refined clinical intuition during intensive chemotherapy cycles.
Patient Consensus: Patients emphasise that treatment in India is physically demanding, often requiring 40 or more nights in hospital for continuous infusions. They note that young patients respond exceptionally well to therapy. However, they underline the need for strict infection control and supportive care during recovery.
Treatment for Burkitt lymphoma in India involves intensive chemotherapy regimens like R-EPOCH. These protocols effectively target fast-growing cancer cells. However, they often cause significant myelosuppression and neutropenic fever. Indian oncology centres manage these effects within JCI-accredited facilities to maintain high survival rates.
Bookimed Expert Insight: Indian centres like HCG Manavata Cancer Centre use specialised TomoTherapy-H and PET-CT imaging. This helps them refine treatment. Our data shows clinics with high transplant volumes provide integrated support for severe side effects. Apollo Hospital is one such clinic. This infrastructure helps patients manage intensive therapies that might otherwise cause prolonged hospital stays.
Patient Consensus: Patients in India find mucositis the most challenging daily struggle. They suggest red-light laser therapy and aggressive oral care to manage painful mouth and throat sores. Persistent nerve tingling and fatigue often require a recovery plan lasting over 12 months.
Burkitt lymphoma treatment in India actively protects the brain and spinal cord through prophylactic chemotherapy. Specialists use intrathecal injections to deliver medicine directly into the spinal fluid. This prevents cancer spread to the central nervous system. Indian centres follow global protocols to manage these risks.
Bookimed Expert Insight: Indian oncology centres often lead in complex case management due to enormous patient volumes. Apollo Hospital Indraprastha has treated 45 million patients from 120 countries. This vast experience means medical teams are highly proficient in administering delicate intrathecal treatments safely. Australian patients benefit from doctors who perform these spinal procedures daily as part of standard care.
Patient Consensus: Patients note that lumbar punctures are a routine part of the cycle. However, they are essential for peace of mind. Some report tingling in hands or feet. They emphasise the primary goal in India: stopping the aggressive disease from reaching the brain.
Standard treatment for Burkitt lymphoma in India involves intensive, short-duration chemotherapy combined with immunotherapy. Clinics such as Artemis Hospitals and Apollo Hospital Indraprastha use multi-agent regimens. These include R-CODOX-M or DA-EPOCH-R. These protocols require immediate hospital admission and include mandatory central nervous system protection.
Bookimed Expert Insight: DA-EPOCH-R is widely used in India to reduce side effects. However, patients should note that this protocol typically requires 40 nights in hospital across 4 months. Major centres like HCG Manavata Cancer Centre often integrate CAR T-cell therapy or bone marrow transplants. They use these for cases that do not respond to initial chemotherapy. This provides a vital second-line option rarely available in smaller regional facilities.
Patient Consensus: Patients note that arriving in India prepared for 5-day hospital stays is essential. These stays occur every 3 weeks. They strongly suggest requesting a port catheter early to handle the intensive intravenous infusions safely.
Stem cell transplants are generally not necessary for initial Burkitt's lymphoma treatment in India. High-intensity chemotherapy is the primary standard. Specialists recommend transplants mainly for relapsed cases or when the disease does not respond to first-line drugs. Indian JCI-accredited hospitals provide both autologous and allogeneic options.
Bookimed Expert Insight: While India is famous for low costs, the real advantage is the volume of complex cases. Apollo Hospital Indraprastha has treated over 45 million patients globally. This massive patient flow means Indian haematologists manage rare Burkitt's complications more frequently than many Western specialists.
Patient Consensus: Patients note that recovery takes time. They often start walking after about 6 weeks. They emphasise that a transplant is not always mandatory if chemotherapy works well initially in India.
Burkitt's lymphoma treatment in India requires urgent hospitalisation. This aggressive cancer needs prompt, intensive chemotherapy. Patients typically stay 4 to 7 days per cycle for regimens like DA-EPOCH-R. Specialised units like those at HCG Manavata Cancer Centre monitor for metabolic issues and infections.
Bookimed Expert Insight: Initial phases require inpatient care. However, long-term costs in India are 30% to 50% lower than in Western countries. Large networks like Manipal Hospitals serve 2 million international patients annually. This high volume means specialists are highly experienced. They handle intensive lymphoma protocols and emergency complications.
Patient Consensus: Patients note they may spend up to 3 weeks per month in Indian hospitals. Frequent admissions for side effects like low white blood cells or mouth sores are common.
Treatment for Burkitt's lymphoma in India typically takes 3 to 6 months. This intensive process involves 4 to 8 cycles of high-dose chemotherapy. Patients usually spend 1 week in hospital per cycle. Specialists begin therapy immediately due to the rapid growth of this lymphoma.
Bookimed Expert Insight: Indian oncology networks like Manipal and Apollo serve over 2 million patients annually. Their high volume means haematologists often manage Burkitt's as a medical emergency. Dr Girish Badarkhe at HCG Manavata even provides CAR T-cell therapy. It is for cases resistant to standard chemotherapy.
Patient Consensus: Patients note the chemotherapy is intensive but highly effective. Many achieve remission within 4 months in India. They recommend a port catheter for continuous IV access over the half-year treatment period.